Optimizing Ancillary Therapies With Immune Checkpoint Inhibitors for Solid Tumors (OAT ICI)
Clinical trial NCT07661459 · RECRUITING
Trial details
- NCT number
- NCT07661459
- Sponsor
- Val Adams
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-26
- Primary completion
- 2027-07-31
- Enrollment
- 98
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.